| Serial Number | 97127774 |
| Word Mark | ALTIBODY |
| Filing Date | Tuesday, November 16, 2021 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Monday, September 30, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Genetic engineering services, namely, the production of genetically-engineered antibodies for others |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, November 22, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Regeneron Pharmaceuticals, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Tarrytown, NY 10591 |
| Event Date | Event Description |
| Friday, November 19, 2021 | NEW APPLICATION ENTERED |
| Monday, November 22, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, January 11, 2022 | ASSIGNED TO EXAMINER |
| Friday, January 14, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, July 14, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, February 1, 2022 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Thursday, July 14, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Thursday, July 14, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, September 30, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, September 30, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, September 30, 2024 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Monday, September 30, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |